Clinical Research Directory

Inclusion Criteria: 1. Male or female patients aged between 18 and 55; 2. Pelvic and hip X-ray showing no severe osteoarthritis (defined as advanced osteoarthritis with large osteophytes, chronic fractures or bone remodeling, severe deformity or bone friction, and/or bone-to-bone contact indicative of severe osteoarthritis/complete loss of cartilage); 3. MRI of the pelvis showing suspected acetabular labral tear; 4. Ability and consent of patients to actively participate in the rehabilitation protocol and clinical follow-up; 5. Signature of informed consent. Exclusion Criteria: 1. Patients incapable of understanding and willing; 2. Diagnosis of leukemia, known presence of metastatic malignant cells, ongoing or planned chemotherapy; 3. Diagnosis of rheumatoid arthritis, Reiter's syndrome, psoriatic arthritis, gout, ankylosing spondylitis, or arthritis resulting from another inflammatory disease; human immunodeficiency virus (HIV) infection, viral hepatitis; chondrocalcinosis; 4. Patients with uncontrolled diabetes mellitus; 5. Patients with uncontrolled thyroid metabolic disorders; 6. Patients who abuse alcohol, drugs, or medications; 7. Body Mass Index \> 40; 8. Pregnancy or breastfeeding, or intention to become pregnant during the study period. 9. Patients with a history of trauma or intra-articular infiltration of therapeutic substances in the 6 months prior to screening. 10. Patients who have undergone hip surgery in the previous 12 months.